Soufflé Therapeutics
Developer of a targeted gene therapy intended to treat autoimmune diseases and cardiac diseases. The company develops a platform for targeted, tissue-specific genetic therapy delivery through the disc...
Valuation
$0
Share Price
N/A
Total Raised
$330.6M
Last Round
N/A